Article Information
History
- March 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Galit Perez, MN MA1,*,
- Tamar Banon, MSc2,
- Sivan Gazit, MD MA1,
- Shay Ben Moshe, MSc3,1,
- Joshua Wortsman, MD1,
- Daniel Grupel, MD3,
- Asaf Peretz, MD4,
- Amir Ben Tov, MD2,5,
- Gabriel Chodick, PhD MHA2,5,
- Miri Mizrahi-Reuveni, MD MHA6 and
- Tal Patalon, MD2
- 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
- 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
- 3Ben-Gurion University, Beer Sheva, Israel
- 4Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod Israel
- 5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- 6Health Division, Maccabi Healthcare Services, Tel Aviv, Israel
- ↵*Corresponding author:
Galit Perez, perez_g{at}mac.org.il
Posted March 08, 2021.
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
